Abiopharma

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

OTC Markets Group Welcomes TelyRx Holdings Inc. to OTCQX

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Roots Announces Details of its Fiscal 2026 First Quarter Results Conference Call

Gold Resource Corporation Announces Special Shareholder Meeting to Vote on Strategic Merger With Goldgroup Mining

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

G-III Apparel Group, LTD. Reports First Quarter Fiscal 2027 Results and Raises Earnings Guidance

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

General Announcement: Change of Name of Wholly-Owned Subsidiaries